References
Sawa Y, Shimazaki Y, Kadoba K, Nishimura M, Matsuda H. Attenuation of cardiopulmonary bypass derived inflammatory reactions reduces myocardial reperfusion injury in open heart surgery. J Thorac Cardiovasc Surg 1996;111:29–35
Ohata T, Sawa Y, Kadoba K, et al. Normothermia has beneficial effects in cardiopulmonary bypass attenuating inflammatory reactions. ASAIO J 1995;41:M288-M291
Inoue T, Takagi M, Sawa Y, Shirakura R, Yoshida T. Oxygen transfer rate of a hybrid artificial lung model. Jpn J Artif Organs 1996;25:811–815
Sawa Y, Kadoba K, Suzuki K, et al. Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome. J Thorac Cardiovasc Surg 1997;113: 512–519
Scott-Burden T, Tock CL, Engler DA. Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular protheses. Circulation 1995;92:I-50 (abstr)
Oz MC, Goldstein DJ, Pepino P. Screening scale predicts successfully receiving long-term inplantable left ventricular assist devices. Circulation 1995;92:II-169–II-193
Akagi H, Takano H, Taenaka Y, et al. Hybrid respiratory support system with extracorporeal placental oxygenation. ASAIO Trans 1991;37:M409–410
Ohata T, Sawa Y, Takagi M, Inoue T, Yoshida T, Kogaki S, Matsuda H. Hybrid artificial lung with interleukin-10 and endothelial constitutive nitric oxide synthase gene-transfected endothelial cells attenuates inflammatory reactions induced by cardiopulmonary bypass. Circulation 1998;98:II-269–II-274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawa, Y., Ohata, T., Takagi, M. et al. Development of hybrid artificial lung with gene transfected biological cells. J Artif Organs 3, 1–4 (2000). https://doi.org/10.1007/BF02479918
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02479918